Title:
核ホルモン受容体モジュレーター
Document Type and Number:
Japanese Patent JP2014509592
Kind Code:
A
Abstract:
The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Inventors:
Keuser Pok, Kevin Pee
Gordon, Thomas Day
Eel, David Sea
Haze, martyne yee
Brainlinger, Eric Sea
Ericsson, Anna Em
Lee, Bin
Wan, Ray
Martinez, Gloria Wye
Birchat, Andrew
Hobson, Adrian Day
Kelly Day
Friedman, Michael
Moaitco, Michael Jei
Gordon, Thomas Day
Eel, David Sea
Haze, martyne yee
Brainlinger, Eric Sea
Ericsson, Anna Em
Lee, Bin
Wan, Ray
Martinez, Gloria Wye
Birchat, Andrew
Hobson, Adrian Day
Kelly Day
Friedman, Michael
Moaitco, Michael Jei
Application Number:
JP2013558163A
Publication Date:
April 21, 2014
Filing Date:
March 15, 2012
Export Citation:
Assignee:
AbbVie Incorporated
International Classes:
C07D213/74; A61K31/05; A61K31/122; A61K31/137; A61K31/167; A61K31/357; A61K31/416; A61K31/4184; A61K31/44; A61K31/4427; A61K31/4439; A61K31/505; A61K31/55; A61P1/04; A61P1/16; A61P3/00; A61P3/04; A61P3/10; A61P3/14; A61P5/38; A61P5/50; A61P7/04; A61P7/10; A61P9/00; A61P9/12; A61P9/14; A61P11/02; A61P11/06; A61P11/08; A61P13/12; A61P17/02; A61P17/04; A61P17/06; A61P19/02; A61P19/08; A61P19/10; A61P25/00; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P27/02; A61P27/06; A61P29/00; A61P31/12; A61P31/18; A61P35/00; A61P35/02; A61P37/02; A61P37/04; A61P37/06; A61P37/08; A61P43/00; C07C45/62; C07C45/65; C07C45/72; C07C45/74; C07C49/747; C07C49/755; C07C67/36; C07C69/76; C07C303/28; C07C309/65; C07D231/54; C07D235/18; C07D239/42; C07D317/72; C07D401/04; C07D401/12; C07D405/12; C07D487/02; C07B53/00; C07B57/00; C07B61/00
Attorney, Agent or Firm:
Kawaguchi International Patent Office